139 results match your criteria: "Paris Centre de Recherche Cardiovasculaire[Affiliation]"
J Clin Endocrinol Metab
April 2019
Équipe Labellisée par la Ligue Contre le Cancer, INSERM, UMR970, Paris-Centre de Recherche Cardiovasculaire, Paris, France.
Circulation
March 2019
Institut National de la Santé et de la Recherche Médicale, UMRS-970, Paris Centre de Recherche Cardiovasculaire, Université Paris Descartes, Sorbonne Paris Cité, France (I.Z., C.P., W.B., J.V., M.L., J.-S-.S.).
Background: Defective systemic and local iron metabolism correlates with cardiac disorders. Hepcidin, a master iron sensor, actively tunes iron trafficking. We hypothesized that hepcidin could play a key role to locally regulate cardiac homeostasis after acute myocardial infarction.
View Article and Find Full Text PDFMed Sci (Paris)
October 2018
Inserm UMR-S 1180, Signalisation et physiopathologie cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France.
Macrophages regulate cardiac homeostasis under pathological and physiological conditions. Recent studies have elegantly substantiated the presence of specific subset of macrophages residing within the distal atrioventricular node in mice and humans. These macrophages directly couple with cardiomyocytes via connexin-43-containing gap junctions and increase atrioventricular conduction by accelerating cardiomyocyte repolarization.
View Article and Find Full Text PDFJ Gastroenterol Hepatol
May 2019
Service de génétique, Centre de Référence des Maladies Vasculaires Rares, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
Background And Aim: Vascular Ehlers-Danlos syndrome (vEDS) is a rare connective tissue disorder due to heterozygous mutations in the COL3A1 gene with a dominant negative effect. Spontaneous bowel perforation and intra-abdominal organ rupture are common complications of vEDS. Other gastrointestinal (GI) manifestations may occur but have not been extensively characterized.
View Article and Find Full Text PDFFront Cardiovasc Med
October 2018
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-970, Paris Centre de Recherche Cardiovasculaire, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
In response to pathophysiological stress, the cardiac tissue undergoes profound remodeling process that incorporates the elimination of dying resident cells, compensatory hypertrophy of functional cardiomyocytes, growth and remodeling of the vascular compartment and formation of a fibrotic scar. Accumulating evidences indicate that cardiac remodeling is, at least in part, controlled by a complex crosstalk between cardiomyocytes and macrophages. The strategic location of abundant macrophages to the proximity of cardiomyocytes suggest that they could regulate the fate of cardiomyocytes in the injured heart.
View Article and Find Full Text PDFEuropace
March 2019
Cardiology Department, European Hospital Georges Pompidou, Paris, France.
Orphanet J Rare Dis
June 2018
Hôpital Européen Georges Pompidou, Département de Génétique, Centre de Référence des Maladies Vasculaires Rares, Hôpital Européen Georges Pompidou, AP-HP, 20-40 rue Leblanc, 75908, Paris Cedex 15, France.
Background: Vascular Ehlers-Danlos syndrome (vEDS) is a rare condition characterized by connective tissue fragility. Direct spontaneous carotid-cavernous fistula (sCCF) is reportedly pathognomonic of vEDS. We conducted this study to understand the possible mechanisms of occurrence of sCCF in this subset of patients.
View Article and Find Full Text PDFHum Mol Genet
October 2018
Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.
Proteoglycans are among the most abundant and structurally complex biomacromolecules and play critical roles in connective tissues. They are composed of a core protein onto which glycosaminoglycan (GAG) side chains are attached via a linker region. Biallelic mutations in B3GALT6, encoding one of the linker region glycosyltransferases, are known to cause either spondyloepimetaphyseal dysplasia (SEMD) or a severe pleiotropic form of Ehlers-Danlos syndromes (EDS).
View Article and Find Full Text PDFArch Cardiovasc Dis
October 2018
Adult Congenital Heart Disease Unit, Centre de Référence des Malformations Cardiaques Congénitales Complexes (M3C), 75015 Paris, France; Cardiology Department, Hôpital Européen Georges-Pompidou, 75015 Paris, France; Paris Descartes University, 75006 Paris, France; Inserm U970, Paris Centre de Recherche Cardiovasculaire, 75015 Paris, France.
Adult congenital heart disease (ACHD) is a constantly expanding population with challenging issues. Initial medical and surgical treatments are seldom curative, and the majority of patients still experience late sequelae and complications, especially thromboembolic events. These common and potentially life-threating adverse events are probably dramatically underdiagnosed.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
May 2018
Heart Institute, Cincinnati Children's Hospital Medical Center, OH (S.B. G.R.V., N.B.)
Background: The Fontan operation has provided life-saving palliation and adult survival for individuals born with single ventricle physiology. Many now seek advice about safe pregnancy. Little data are, however, available, consisting mainly of anecdotal experience and small series.
View Article and Find Full Text PDFAnn Pathol
April 2018
Département de pathologie, hôpital Cochin, université Paris Descartes, Assistance publique-hôpitaux de Paris, 74014 Paris, France.
Lung cancer is the leading cause of cancer death in France with low response rates to conventional chemotherapy. Nevertheless, new therapies have emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab (OPDIVO, Bristol-Myers Squibb) and pembrolizumab (KEYTRUDA, Merck & Co), or PD-L1 ICI, such as atezolizumab (TECENTRIQ, Genentech), durvalumab (IMFINZI, Astra-Zeneca), and avelumab (BAVENCIO, EMD Serono). The prescription of pembrolizumab for advanced stage non-small cell lung carcinoma (NSCLC) patients requires the demonstration of PD-L1 expression by tumor cells by immunohistochemistry (IHC) (minimum of 50% of positive tumor cells is required for first-line setting, and of 1% for second-line and beyond) and PD-L1 assay is now considered as a companion diagnostic tool for this drug.
View Article and Find Full Text PDFEur Heart J
May 2018
Adult Congenital Heart Disease Unit, Department of Cardiology, Hôpital Européen Georges Pompidou, France.
Eur J Hum Genet
June 2018
Département de Génétique, Service de Médecine Vasculaire et Centre de Référence des Maladies Vasculaires Rares, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
Background: Echocardiographic assessment of diastolic function in the setting of Fontan physiology is not well validated. We recently demonstrated that atrioventricular systolic to diastolic duration ratio (AVV S/D ratio) independently predicts mortality in Fontan-adults and that a value >1.1 was associated with poor prognosis.
View Article and Find Full Text PDFCancer Res
April 2018
INSERM, UMR970, Paris-Centre de Recherche Cardiovasculaire, Paris, France; Equipe labellisée Ligue contre le Cancer.
Comprehensive genetic analyses have identified germline and gene mutations as predominant causes of metastatic paraganglioma and pheochromocytoma. However, some suspicious cases remain unexplained. In this study, we performed whole-exome sequencing of a paraganglioma exhibiting an -like molecular profile in the absence of or mutations and identified a germline mutation in the gene, which encodes the mitochondrial 2-oxoglutarate/malate carrier.
View Article and Find Full Text PDFEur Heart J
May 2018
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-970, Paris Centre de Recherche Cardiovasculaire, 56, rue Leblanc, 75015 Paris, France.
Aims: We have shown that extracellular vesicles (EVs) secreted by embryonic stem cell-derived cardiovascular progenitor cells (Pg) recapitulate the therapeutic effects of their parent cells in a mouse model of chronic heart failure (CHF). Our objectives are to investigate whether EV released by more readily available cell sources are therapeutic, whether their effectiveness is influenced by the differentiation state of the secreting cell, and through which mechanisms they act.
Methods And Results: The total EV secreted by human induced pluripotent stem cell-derived cardiovascular progenitors (iPSC-Pg) and human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) were isolated by ultracentrifugation and characterized by Nanoparticle Tracking Analysis, western blot, and cryo-electron microscopy.
Kidney Int Rep
January 2018
Centre de recherches en Epidémiologie et Santé des Populations, Inserm, University of Paris-Sud, University of Versailles Saint-Quentin, University of Paris-Saclay, Villejuif, France.
Introduction: Reducing protein intake is recommended for slowing chronic kidney disease (CKD) progression, but assessment of its true effectiveness is sparse.
Methods: Using the Maroni formula, we assessed dietary protein intake (DPI) from 24-hour urinary urea excretion in 1594 patients (67% men and 33% women) with CKD, 784 of whom also had 7-day food records. Cause-specific hazard ratios (HRs) and 95% confidence intervals for the competing risks of DPI-associated end-stage renal disease (ESRD) or death were estimated in 1412 patients with baseline glomerular filtration rate ≥15 ml/min per 1.
J Hypertens
March 2018
INSERM U970, Paris Centre de Recherche Cardiovasculaire, Paris Descartes University.
Background: Left ventricular (LV) remodeling and aortic stiffness have independent predictive value for all causes and cardiovascular mortality. Because elastic properties of the arterial wall vary along the aortic pathway, we hypothesized that local and regional aortic stiffness could differently impact on LV remodeling.
Methods And Results: Regional aortic stiffness was determined from carotid-femoral pulse wave velocity (cfPWV) measured by aplanation tonometry.
J Am Coll Cardiol
January 2018
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-970, Paris Centre de Recherche Cardiovasculaire, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Pathol Oncol Res
January 2019
Thoracic Surgery and Lung Transplantation Department, Georges Pompidou European Hospital, Assistance Publique Hôpitaux de Paris, 20 rue Leblanc, 75908, Paris Cedex 15, France.
Mutational heterogeneity could explain different metastatic patterns among IIIA-N2 lung cancer and influence prognosis. The identification of subclonal mutations using deep sequencing to evaluate the degree of molecular heterogeneity may improve IIIA-N2 classification. The aim of this prospective study was to assess mutational and immunohistochemical characteristics in primary tumours and involved lymph nodes (LN) in operated patients.
View Article and Find Full Text PDFCancers (Basel)
August 2017
INSERM UMR-S1147, CNRS SNC 5014, Saints-Pères Research Center, 45 rue des Saints-Pères Paris-Descartes University, Sorbonne Paris Cité University, 75006 Paris, France.
Despite major advances, non-small cell lung cancer (NSCLC) remains the major cause of cancer-related death in developed countries. Metastasis and drug resistance are the main factors contributing to relapse and death. Epithelial-to-mesenchymal transition (EMT) is a complex molecular and cellular process involved in tissue remodelling that was extensively studied as an actor of tumour progression, metastasis and drug resistance in many cancer types and in lung cancers.
View Article and Find Full Text PDFCirculation
June 2017
From Centre de référence des Malformations Cardiaques Congénitales Complexes, M3C, Paris, France (M.L., S.H.); Adult Congenital Heart Disease Unit, Department of Cardiology, Hôpital Européen Georges Pompidou and Necker Hospital, APHP, Paris Descartes University, Paris Centre de Recherche Cardiovasculaire, INSERM U970, France (M.L.); Department of Obstetrics and Gynecology, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France (L.B., J.N.); Centre de Compétence des Malformations Cardiaques Congénitales Complexes, M3C, Service de Cardiologie, CHU de Rennes, France (A.B.); Cardiologie Congénitale, Strasbourg, France (J.R.); Pediatric and Congenital Cardiology Department, University Hospital, CHU d'Angers, France (Q.H.); Department of Congenital Heart Diseases, Hôpital Marie Lannelongue, Faculté de Médecine Paris-Sud, Université Paris Sud, Université Paris-Saclay, Plessis-Robinson, France (S.H.); Cardiology Department, Hôpital Pasteur, Université de Nice Sophia-Antipolis, France (P.M.); Adult Congenital Heart Disease, Institut du thorax, CHU de Nantes, France (L.L.); Pediatric and Congenital Cardiology Department, M3C Regional Reference Center, University Hospital, Physiology and Experimental Biology of Heart and Muscles Laboratory, PHYMEDEXP, UMR CNRS 9214, INSERM U1046, University of Montpellier, France (P.A.); Pediatric and Congenital Cardiology Department, M3C Regional Antilles-Guyane Tertiary Care Center, University Hospital of Martinique, FWI, Fort de France (H.L.); Maladies Cardiovasculaires Infantiles et Congénitales, Lille, France (A.R.); Cardiology Department, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France (M.G.); and Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR 7222, INSERM U1150 (J.N.).
Nephrol Ther
November 2017
Club des jeunes néphrologues, 11, rue Auguste-Mourcou, 59000 Lille, France; Service d'explorations fonctionnelles rénales et métaboliques, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75908 Paris, France; Université Paris Descartes, faculté de médecine, 15, rue de l'École-de-Médecine, 75006 Paris, France. Electronic address:
Am J Surg Pathol
July 2017
*Department of Pathology †Department of Urology, European Georges Pompidou Hospital, APHP ‡Medical Faculty of Paris-Descartes University, Paris §PREDIR, National Expert Network of INCA for Rare Adult Cancers "Hereditary Predisposition to Renal Tumours", APHP, Bicetre Hospital, Le Kremlin-Bicêtre ∥INSERM U1186, Oncogenetic Laboratory, EPHE, PSL, Institut of Cancerology Gustave Roussy, Villejuif ¶Department of Pathology, Necker-Enfants Malades hospital, APHP, Paris **INSERM, UMR970, Paris-Centre de Recherche Cardiovasculaire, Paris, France.
Nat Commun
May 2017
Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
The indigenous populations of the South Pacific experience a high burden of rheumatic heart disease (RHD). Here we report a genome-wide association study (GWAS) of RHD susceptibility in 2,852 individuals recruited in eight Oceanian countries. Stratifying by ancestry, we analysed genotyped and imputed variants in Melanesians (607 cases and 1,229 controls) before follow-up of suggestive loci in three further ancestral groups: Polynesians, South Asians and Mixed or other populations (totalling 399 cases and 617 controls).
View Article and Find Full Text PDF